Mink Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.5% | -16.2% | +38.9% | -14.0% | -5.8% | -3.9% | -10.5% | -11.7% | -6.5% | 0.0% | – | |
| – | +17.3% | -46.3% | -26.2% | +102.1% | -55.8% | +51.5% | +51.7% | -30.8% | -8.8% | +11.4% | -33.0% | – | |
| – | – | -51.0% | -112.8% | – | – | – | +97.5% | -9.1% | -55.8% | -26.9% | +71.0% | – | |
| – | +219.2% | -100.0% | -100.0% | – | – | – | – | – | +50.0% | -100.0% | – | – | |
| – | +318,814.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -200.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -100.1% | – | +16.0% | -99.9% | -100.0% | – | -99.9% | +2,508,358.9% | -91.3% | -278.8% | – | – | |
| – | – | – | +42.7% | -185.4% | – | – | – | – | -107.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.